tiprankstipranks
23andMe Cuts 40% of Staff, Shutters Drug Development Ahead of Q2 Print
PremiumMarket News23andMe Cuts 40% of Staff, Shutters Drug Development Ahead of Q2 Print
2M ago
23andMe to reduce overall headcount by 40% of workforce
Premium
The Fly
23andMe to reduce overall headcount by 40% of workforce
2M ago
ME Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ME Upcoming Earnings Report: What to Expect?
2M ago
23andMe Announces Reverse Stock Split and Strategic Adjustments
PremiumCompany Announcements23andMe Announces Reverse Stock Split and Strategic Adjustments
3M ago
23andMe announces completion of 1-for-20 reverse stock split
Premium
The Fly
23andMe announces completion of 1-for-20 reverse stock split
3M ago
23andMe trading halted, news pending
Premium
The Fly
23andMe trading halted, news pending
3M ago
23andMe CEO says not open to considering ‘third party takeover proposals’
PremiumThe Fly23andMe CEO says not open to considering ‘third party takeover proposals’
4M ago
23andMe launches genetic report on likelihood of emotional eating
Premium
The Fly
23andMe launches genetic report on likelihood of emotional eating
4M ago
Playtika to acquire SuperPlay, Intel says not selling Mobileye: Morning Buzz
Premium
The Fly
Playtika to acquire SuperPlay, Intel says not selling Mobileye: Morning Buzz
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100